KCAS Bio is exhibiting at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 11th-15th, 2026, in Boston, MA. This event serves as a global hub for scientific discovery and collaboration, bringing together leaders and innovators in the field of gene and cell therapy.
Pioneering Bioanalytical Solutions for Cell and Gene Therapies
Cell and gene therapies are transforming the landscape of modern medicine, offering groundbreaking treatments for diseases once considered untreatable. KCAS Bio is at the forefront of this evolution, providing specialized bioanalytical services designed to support the unique needs of these therapies. From vector quantification and potency assays to immunogenicity and pharmacokinetics, our team leverages state-of-the-art technologies and deep scientific expertise to deliver high-quality data that propels therapeutic development forward.
Join Us at ASGCT 2026 in Boston
KCAS Bio invites you to meet with our team during ASGCT 2026 to discover how our bioanalytical expertise can support your cell and gene therapy projects. Whether you’re tackling unique challenges or seeking a partner to accelerate your development, we’re here to provide tailored solutions that meet your needs. Contact us today to schedule a meeting at the conference and take the first step toward advancing your research. Together, we can drive meaningful progress in cell and gene therapy innovation.